Paul Gregor
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$7.9MFederal grants as PI11 awards
0Patents grantedNone matched
43Papers3,462 citations
Federal awards and patents by year
AwardsPatents
11 awards · $7.9M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 19, 2024 | NIH | SBIR Phase II Amyloid-Beta and Tau/Glycosaminoglycan Dual Inhibitor for Alzheimer's Disease | $1.2M | GISMO THERAPEUTICS INC. |
| Jul 20, 2023 | NIH | SBIR Phase II Amyloid-Beta and Tau/Glycosaminoglycan Dual Inhibitor for Alzheimer's Disease | $793K | GISMO THERAPEUTICS INC. |
| Sep 1, 2022 | NIH | SBIR Phase II Amyloid-Beta and Tau/Glycosaminoglycan Dual Inhibitor for Alzheimer's Disease | $1.8M | GISMO THERAPEUTICS INC. |
| Aug 25, 2022 | NIH | SBIR Phase II Amyloid-Beta and Tau/Glycosaminoglycan Dual Inhibitor for Alzheimer's Disease | $984K | GISMO THERAPEUTICS INC. |
| Jun 11, 2018 | NIH | SBIR Phase II Glycosaminoglycan-Interacting Small Molecule (GISMO) as Alzheimer's Therapeutics | $952K | GISMO THERAPEUTICS INC. |
| Aug 25, 2017 | NIH | SBIR Phase II Glycosaminoglycan-Interacting Small Molecule (GISMO) as Alzheimer's Therapeutics | $933K | GISMO THERAPEUTICS INC. |
| Jul 18, 2017 | NIH | SBIR Phase I Glycosaminoglycan-Interacting Small Molecule (GISMO) as Parkinson's Therapeutic | $142K | GISMO THERAPEUTICS INC. |
| Aug 1, 2016 | NIH | SBIR Phase I Glycosaminoglycan Interacting Small Molecule GISMO as Parkinson s Therapeutic | $384K | GISMO THERAPEUTICS INC. |
| Jul 25, 2016 | NIH | SBIR Phase I Glycosaminoglycan-Interacting Small Molecule (GISMO) as Parkinson's Therapeutic | $242K | GISMO THERAPEUTICS INC. |
| Apr 1, 2015 | NIH | SBIR Phase I Glycosaminoglycan-Cytokine Inhibitors for Arthritis Therapy | $225K | GISMO THERAPEUTICS INC. |
| Mar 23, 2015 | NIH | SBIR Phase I Glycosaminoglycan-Cytokine Inhibitors for Arthritis Therapy | $225K | GISMO THERAPEUTICS INC. |
1 patents as inventor
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#116
Awards as PI#106
Patents#273
Companies
- GISMO THERAPEUTICS INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.